MARKET

IMTX

IMTX

Immatics N.V
NASDAQ
9.45
+0.09
+0.96%
After Hours: 9.35 -0.1 -1.06% 19:30 08/28 EDT
OPEN
9.68
PREV CLOSE
9.36
HIGH
9.89
LOW
9.32
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
12.41
52 WEEK LOW
5.05
MARKET CAP
1.44B
P/E (TTM)
-5.2075
1D
5D
1M
3M
1Y
5Y
1D
Immatics Raises $161 Million in Completed Equity Offering to Advance PRAME Cancer Programs
TipRanks · 2d ago
Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma
Seeking Alpha · 4d ago
Immatics price target lowered to $17 from $18 at Jefferies
TipRanks · 4d ago
Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday
Benzinga · 4d ago
Immatics Announces $150 Million Underwritten Offering; Stock Up
NASDAQ · 4d ago
Immatics launches $150M securities offering
Seeking Alpha · 4d ago
Immatics announces $150M offering of common stock priced at $8.69 per share
TipRanks · 4d ago
Immatics Announces $150M Underwritten Offering Of Ordinary Shares And Pre-Funded Warrants
Benzinga · 4d ago
More
About IMTX
Immatics N.V. is a clinical-stage biopharmaceutical company. The Company is primarily engaged in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics.PRAME is a target expressed approximately 50 cancers. Its PRAME franchise includes approximately three product candidates, two therapeutic modalities and three combination therapies that target PRAME: anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy, IMA203CD8 PRAME cell therapy, IMA402 PRAME bispecific as monotherapy, in combination with immune checkpoint inhibitors, in combination with IMA401 MAGEA4/8 bispecific as well as anzu-cel in combination with Moderna’s PRAME mRNA designed to enhance cell therapy. The Company has approximately two technology platforms for target and T Cell Receptor (TCR) discovery.

Webull offers Immatics NV stock information, including NASDAQ: IMTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMTX stock methods without spending real money on the virtual paper trading platform.